122
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

The expression of heparanase in term and preterm human placentas

ORCID Icon, , , , &
Pages 5840-5845 | Received 12 May 2020, Accepted 23 Feb 2021, Published online: 10 Mar 2021

References

  • Freeman C, Parish CR. Human platelet heparanase: purification, characterization and catalytic activity. Biochem J. 1998;330(3):1341–1350.
  • Weiss RJ, Esko JD, Tor Y. Targeting heparin and heparan sulfate protein interactions. Org Biomol Chem. 2017;15(27):5656–5668.
  • Vlodavsky I, Eldor A, Haimovitz-Friedman A, et al. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis. 1992;12(2):112–127.
  • Goshen R, Hochberg AA, Korner G, et al. Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts. Mol Hum Reprod. 1996;2(9):679–684.
  • Vlodavsky I, Beckhove P, Lerner I, et al. Significance of heparanase in cancer and inflammation. Cancer Microenviron. 2012;5(2):115–132.
  • Vlodavsky I, Goldshmidt O, Zcharia E, et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol. 2002;12(2):121–129.
  • Lorente-Gea L, García B, Martín C, et al. Heparan sulfate proteoglycans and heparanases in Alzheimer’s disease: current outlook and potential therapeutic targets. Neural Regen Res. 2017;12(6):914–915.
  • Pisano C, Vlodavsky I, Ilan N, et al. The potential of heparanase as a therapeutic target in cancer. Biochem Pharmacol. 2014;89(1):12–19.
  • Tatour M, Shapira M, Axelman E, et al. Thrombin is a selective inducer of heparanase release from platelets and granulocytes via protease-activated receptor-1. Thromb Haemost. 2017;117(7):1391–1401.
  • Shafat I, Vlodavsky I, Ilan N. Characterization of mechanisms involved in secretion of active heparanase*. J Biol Chem. 2006;281(33):23804–23811.
  • Dempsey LA, Plummer TB, Coombes SL, et al. Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology. 2000;10(5):467–475.
  • Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: key pieces of the development puzzle. Science. 1994;266(5190):1508–1518.
  • Nadir Y, Henig I, Naroditzky I, et al. Involvement of heparanase in early pregnancy losses. Thromb Res. 2010;125(5):e251–e257.
  • Ginath S, Lurie S, Golan A, et al. The expression of heparanase in normal and preeclamptic placentas. J Matern Fetal Neonatal Med. 2015;28(13):1589–1593.
  • Famá EAB, Souza RS, Melo CM, et al. Evaluation of glycosaminoglycans and heparanase in placentas of women with preeclampsia. Clin Chim Acta. 2014;437:155–160.
  • Nadir Y, Kenig Y, Drugan A, et al. Involvement of heparanase in vaginal and cesarean section deliveries. Thromb Res. 2010;126(6):e444–e450.
  • Haimov-Kochman R, Friedmann Y, Prus D, et al. Localization of heparanase in normal and pathological human placenta. Mol Hum Reprod. 2002;8(6):566–573.
  • Martin JA, Hamilton BE, Osterman MJ, et al. Births: final data for 2013. Natl Vital Stat Rep Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst. 2015;64:1–65.
  • Romero R, Espinoza J, Kusanovic J, et al. The preterm parturition syndrome. BJOG Int J Obstet Gynaecol. 2006;113:17–42.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
  • Nelson DM, Burton GJ. A technical note to improve the reporting of studies of the human placenta. Placenta. 2011;32(2):195–196.
  • Yagel S. Angiogenesis in gestational vascular complications. Thromb Res. 2011;127:S64–S66.
  • Eddy AC, Chapman H, George EM. Heparanase regulation of sFLT-1 release in trophoblasts in vitro. Placenta. 2019;85:63–68.
  • Che G, Wang Y, Zhou B, et al. Knockdown of heparanase suppresses invasion of human trophoblasts by activating p38 MAPK signaling pathway. Dis Markers. 2018;2018:7413027.
  • Nadir Y, Brenner B. Heparanase—a link between coagulation, angiogenesis, and cancer. rambam maimonides. Med J. 2012;3(1):e0002.
  • Nadir Y, Brenner B, Zetser A, et al. Heparanase induces tissue factor expression in vascular endothelial and cancer cells. J Thromb Haemost. 2006;4(11):2443–2451.
  • Wu W, Pan C, Meng K, et al. Hypoxia activates heparanase expression in an NF-kappaB dependent manner. Oncol Rep. 2010;23:255–261.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.